Flu Vaccines: Current and Novel Approach
Flu Vaccine is an annual vaccination using a vaccine that is specific for a given year to protect against the highly variable influenza virus. Risk management and effectiveness of vaccines are important for public health. In the United States, NIAID laboratories are developing novel vaccine candidates for seasonal influenza viruses and for avian strains with pandemic potential. In late 2006, the NIAID Vaccine Research Center initiated the first human trial of an investigational DNA vaccine against the H5N1 avian influenza virus, a strain that has infected and continues to threaten humans. In addition, researchers in the NIAID Laboratory of Infectious Diseases are working with MedImmune to generate candidate live-attenuated vaccines for a broad range of influenza subtypes with pandemic potential. To date, five of these vaccine candidates have advanced to Phase I clinical trials. Many Ebola vaccine candidates had been developed in the decade prior to 2014, but none has yet been approved for clinical use in humans.
Flu Vaccine can be defined as a biological preparation that provides active acquired immunity to a flu disease. Flu vaccination by injection, commonly known as the "flu jab" is available every year on the for adults (and some children) at risk of flu and its complications. For improving vaccine immunogenicity adjuvants are used. Vaccine Adjuvants – It can be defined as a component which potentiates the immune system and accelerates the immune responses to an antigen.These components act to induce, prolong, and enhance antigen-specific immune responses when used in combination with specific vaccine antigens. Aluminum salts are the only licensed adjuvant in the United States, but the combination of these salts with inactivated influenza A/H5N1 antigens has had little effect on seroresponses. Several oil-in-water adjuvants, including MF59 and AS03, have significantly enhanced immune responses in healthy adult vaccine recipients to inactivated influenza A/H5N1.
- Genetic and evolution of virus and host
- Risk management and effectiveness of vaccines
- Targeting strategies for influenza vaccines
- Adjuvants and their improvement issues
- Clinical trails of influenza based vaccines
- Epidemiology and prevention of vaccine
- Ebola Vaccine
Related Conference of Flu Vaccines: Current and Novel Approach
Annual meeting on Infectious Diseases, Microbiology & Beneficial Microbes
5th International Conference on Infectious Diseases: Control and Prevention
7th International Conference on Infectious Diseases, Bacteriology and Antibiotics
7th International conference on Parasitology, Microbiology and Infection Control
Flu Vaccines: Current and Novel Approach Conference Speakers
Recommended Sessions
- Antivirals and Therapeutics
- Emerging Infectious Disease
- Entrepreneurs Investment Meet
- Epidemiology and Public Health of Influenza
- Flu Clinical Studies & Case Reports
- Flu Symptoms & Treatment
- Flu Vaccine: Manufactures & Market Analysis
- Flu Vaccines and Vaccination: Opportunities and Challenges for All Age Groups
- Flu Vaccines: Current and Novel Approach
- Flu Virus -Advancements in Detection & Differentiation
- Flu: Immunology & Genetics
- Laws and Ethical Issues Related to Flu Research
- Pathology of Influenza Virus Infections
- Surveillance Issues and Burden of Disease
Related Journals
- Virology & Mycology
- Journal of Virology & Antiviral Research
- Journal of Vaccines & Vaccination
- Journal of Clinical & Cellular Immunology
- Clinical Microbiology : Open Access More
Are you interested in
- AIDS - Infectious Diseases Meet 2020 (Thailand)
- Antibiotics and Inflammation - Infectious Diseases Meet 2020 (Thailand)
- Antimicrobial Agents and Chemotherapy - Infectious Diseases Meet 2020 (Thailand)
- Cancer Epidemiology, Biomarkers & Prevention - Infectious Diseases Meet 2020 (Thailand)
- Clinical Microbiology, Bone and Joint Infections - Infectious Diseases Meet 2020 (Thailand)
- Critical Care Medicine and Experimental Medicine - Infectious Diseases Meet 2020 (Thailand)
- Dental and Oral Infectious Diseases - Infectious Diseases Meet 2020 (Thailand)
- Ebola and Zika Viral Infections - Infectious Diseases Meet 2020 (Thailand)
- Emerging Infectious Disease Update - Infectious Diseases Meet 2020 (Thailand)
- Gastrointestinal & Urinary Tract Infections - Infectious Diseases Meet 2020 (Thailand)
- Global Infectious Diseases - Infectious Diseases Meet 2020 (Thailand)
- HIV/AIDS Prevention, Medicine Research and Control - Infectious Diseases Meet 2020 (Thailand)
- Hospital Mortality due to Infections: Dengue: A Global Threat - Infectious Diseases Meet 2020 (Thailand)
- Immunization and Infection Control - Infectious Diseases Meet 2020 (Thailand)
- Infectious Diseases in Obstetrics and Gynecology - Infectious Diseases Meet 2020 (Thailand)
- International Child Health and Paediatric Infections - Infectious Diseases Meet 2020 (Thailand)
- Medical Health Care and Womens Health Issues - Infectious Diseases Meet 2020 (Thailand)
- Microbial Drug Ressistance - Infectious Diseases Meet 2020 (Thailand)
- Microbiology and Bacteriology - Infectious Diseases Meet 2020 (Thailand)
- Molecular Immunology and Gut Microbes Research - Infectious Diseases Meet 2020 (Thailand)
- Neuro Infectious Diseases - Infectious Diseases Meet 2020 (Thailand)
- Neuro Infectious Diseases - Infectious Diseases Meet 2020 (Thailand)
- Sexually Transmitted Infections - Infectious Diseases Meet 2020 (Thailand)
- track 1 - Infectious Diseases Meet 2020 (Thailand)
- Tropical Medicine and Infectious diseases - Infectious Diseases Meet 2020 (Thailand)
- Tuberculosis and Pneumonia - Infectious Diseases Meet 2020 (Thailand)
- Vaccine Immunology and Therapeutics - Infectious Diseases Meet 2020 (Thailand)
- Virology : Research Advancements - Infectious Diseases Meet 2020 (Thailand)